Luyan Pharma Co.,Ltd.

¥9.53As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002788Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (5.58%)
Div yield 3.67%
ROE 8.09%
Pharmaceutical Retailers
Beta (5Y) 0.07
PE TTM 13.61
TSR TTM 15.60%
Mkt cap ¥3.703B
ROIC 5.07%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥12
26.59%
53.38%
Hold 8|5|11|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.17
0.19
0.18
0.20
1.39%
7.16%
5.59%
17.08%
Revenue¥M
475.4
461.4
457.4
466.1
18.00%
11.70%
5.76%
1.93%
Peers (US$555.0M)
Cap (US$)
PE
871.9M
230.3x
828.1M
22.01x
770.4M
34.16x
Capital
TTM
5Y
10Y
Leveragex
2.224
0.460
0.380
EBIT/Intx
1.054
0.113
0.113
Own earn%
(3.76)
75.09
75.13
Sh yield%
42.21
51.47
49.27
Owners
Insiders/Inst%
10.14
46.68
Short interest%
4.32
SBC / revenue%
0.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
28–38
$1 testx
—
Incr. ROIC%
3